Difference between revisions of "User:Scmohr/Documentation Score"

(→‎Main Page)
(→‎Design Page)
Line 23: Line 23:
 
Answers the question: <SPAN style= 'color:red'>"How did you make it?"</span>
 
Answers the question: <SPAN style= 'color:red'>"How did you make it?"</span>
  
−
7. Raison d’être for constructing the part.* Links to related parts from the same project. [Details in addition to those under items (5) and (6).]  
+
7. Raison d’être for constructing the part.* <SPAN style= 'color:red'>'''(3)'''</span>
−
8. DNA sequence without the BioBrick ends.*  
+
Links to related parts from the same project. <SPAN style= 'color:blue'>'''(2)'''</span>
−
9. Primers used (if part was created using PCR*).  
+
[Details in addition to those under items (5) and (6).]
−
10. Synthesis details (if part was created by DNA synthesis*).  
+
−
11. Special design features: (a) insertion/removal of BioBrick cloning sites, (b) codon optimization, (c) reverse orientation, (d) added tags…*  
+
8. DNA sequence without the BioBrick ends.* <SPAN style= 'color:red'>'''(0)'''</span>
−
13. Graphical sequence bar with all appropriate feature annotations.  
+
 
 +
9. Primers used (if part was created using PCR).* <SPAN style= 'color:red'>'''(2)'''</span>
 +
 
 +
10. Synthesis details (if part was created by DNA synthesis*). <SPAN style= 'color:red'>'''(1)'''</span>
 +
 +
11. Special design features: (a) insertion/removal of BioBrick cloning sites, (b) codon optimization, (c) reverse orientation, (d) added tags…* <SPAN style= 'color:blue'>'''(2)'''</span>
 +
 
 +
13. Graphical sequence bar ''with all appropriate feature annotations.'' <SPAN style= 'color:red'>'''(1)'''</span>
 +
 
14. One-to-three references to literature* on the part’s biological function and uses in synthetic biology. Frequently there is a key reference reporting on the first use or design of a modified version of the protein (see entries under “Reporters”). If no published references are available, cite other sources used (such as online, open-access textbooks, Open Wetware pages, etc.)  
 
14. One-to-three references to literature* on the part’s biological function and uses in synthetic biology. Frequently there is a key reference reporting on the first use or design of a modified version of the protein (see entries under “Reporters”). If no published references are available, cite other sources used (such as online, open-access textbooks, Open Wetware pages, etc.)  
 
15. Difficulties/pitfalls encountered in the design process. Unworkable designs, necessary revisions etc. If everything worked exactly as planned, say so!*  
 
15. Difficulties/pitfalls encountered in the design process. Unworkable designs, necessary revisions etc. If everything worked exactly as planned, say so!*  

Revision as of 17:14, 27 June 2008

ESSENTIAL ITEMS FOR ALL PARTS

Main Page

(10 points)

Answers the question: "What is it?"

0. Designer/iGEM team.* (1)

1. Part number. (alternatively “Accession number”)* (0)

2. Short name.* (1)

3. Extended name. (alternatively an informative title)* (2)

4. Origin (biological species if available, otherwise name the source: "supplied by __________" or "designed, based on ____________").* (3)

5. A short abstract that tells (a) what the part does (function), (b) how it works (mechanism) and (c) why you made it (purpose).* (3)

6. Dependencies: other parts, special materials, cofactors, chassis, etc. (1) (if applicable)

Design Page

Answers the question: "How did you make it?"

7. Raison d’être for constructing the part.* (3) Links to related parts from the same project. (2) [Details in addition to those under items (5) and (6).]

8. DNA sequence without the BioBrick ends.* (0)

9. Primers used (if part was created using PCR).* (2)

10. Synthesis details (if part was created by DNA synthesis*). (1)

11. Special design features: (a) insertion/removal of BioBrick cloning sites, (b) codon optimization, (c) reverse orientation, (d) added tags…* (2)

13. Graphical sequence bar with all appropriate feature annotations. (1)

14. One-to-three references to literature* on the part’s biological function and uses in synthetic biology. Frequently there is a key reference reporting on the first use or design of a modified version of the protein (see entries under “Reporters”). If no published references are available, cite other sources used (such as online, open-access textbooks, Open Wetware pages, etc.) 15. Difficulties/pitfalls encountered in the design process. Unworkable designs, necessary revisions etc. If everything worked exactly as planned, say so!* 16. List all applicable patents and materials transfer agreements (MTAs). [Give link to disclaimer page on IP & iGEM issues.] [edit] Experience Page (How well does it work?) 17. Summary of actual applications to date in originating laboratory.* 18. Measurements or tests of part. Include efficiency. 19. Uploaded data, figures etc. can be put on the Registry wiki and linked here. [edit] Hard Information Page (Reference data) 20. Sequence (FASTA format).* 21. Exact source of the original sequence(s) used to construct the part. GenBank accession number (“VERSION”) and/or “GI” (aka “gi”) number if available. Otherwise any available published sequence or other source of information, including experimental sequence reads (which can be put on the Registry wiki and linked here).* 22. More features (exact details of modified sequences). [edit] POSSIBLE ENHANCEMENTS (Liven it up, use visual materials!) [edit] Main Page 1. Structure cartoon(s). PDB_IDs. 2. Figures relating to the function and/or physical characteristics of the part. (Include forward and reverse efficiencies if known.) [edit] Experience Page 3. Tables of measurements. 4. Figures depicting functional output. 5. Links to additional databases.